Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1

Conditions

Lymphoma 54Lymphoma, Large B-Cell, Diffuse 49Lymphoma, Non-Hodgkin 48Lymphoma, Mantle-Cell 37Lymphoma, Follicular 32Hodgkin Disease 28Lymphoma, Large-Cell, Immunoblastic 23Burkitt Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioblastoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 17Lymphoma, B-Cell, Marginal Zone 15Gliosarcoma 15Brain Neoplasms 15Central Nervous System Neoplasms 14Neoplasms, Plasma Cell 11Glioma 11Astrocytoma 11Leukemia 10Lymphoma, B-Cell 9Recurrence 7Lymphoma, T-Cell 7Waldenstrom Macroglobulinemia 5Oligodendroglioma 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4

Interventions

Cyclophosphamide 82Imatinib Mesylate 81fludarabine phosphate 67fludarabine 62Whole-Body Irradiation 55Mycophenolic Acid 54Tacrolimus 42nilotinib 40Busulfan 39Dasatinib 32Cyclosporine 30Peripheral Blood Stem Cell Transplantation 28thymoglobulin 25Melphalan 25Thiotepa 24Cytarabine 24Granulocyte Colony-Stimulating Factor 23Antilymphocyte Serum 23Methotrexate 21Filgrastim 21Stem Cell Transplantation 20ponatinib 16Sirolimus 16sargramostim 14Cord Blood Stem Cell Transplantation 13Rituximab 11Cyclosporins 11Clofarabine 11venetoclax 10peginterferon alfa-2b 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Carmustine × Clear all
NCT00003727 2019-11-04

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

University of Maryland, Baltimore

Phase 2 Completed
22 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00002766 2016-02-22

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
170 enrolled 7 charts
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Lymphoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡